Related Experiment Video
Updated: Aug 15, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Zidovudine-related anemia with reticulocytosis
1Department of Medicine, Cook County Hospital, Hektoen Building, Room 817, Chicago, IL 60612, USA.
Abstract:
In patients infected with human immunodeficiency virus (HIV), zidovudine has been known to cause a severe hypoproliferative anemia that resolves promptly when the drug is stopped. Some patients, however, may come to medical attention after having stopped taking the drug for 1-2 weeks and may already be in the recovery phase and present with severe anemia, normoblastemia, and reticulocytosis. These features can be mistaken for hemolytic disease, as shown by our experience with three such patients.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Cytomegalovirus Disease
Respiratory Syncytial Virus Disease
Cryptococcal Meningitis
Antiviral Nucleoside Inhibitors

